Blog AIDS 2014, 21 July 2014

The Creative and Novel Ideas in HIV Research (CNIHR) Programme is presented by the International AIDS Society (IAS) in collaboration with the Centers for AIDS Research Program (CFAR) and the U.S. National Institutes of Health (NIH). The programme aims to encourage innovation in the field of HIV research by providing one to two years of funding to early-stage scientists who do not have prior work experience with HIV. The CNIHR Programme allows the grantees the opportunity to conduct cutting-edge research on HIV and AIDS.

In conjunction with the XIX International AIDS Conference (AIDS 2012), CNIHR grants totaling US$5 million were awarded to twelve scientists, including Dr Gretchen Neigh for her proposed work, "Effects of adolescent stress and HIV on the stress response and neuroinflammation." As anticipation grows for the AIDS 2014 conference in Melbourne, Australia, this summer, the IAS has reached out to Dr Neigh to hear her opinions on how the award has shaped her career thus far.

Blog AIDS 2014, 21 July 2014

MELBOURNE, Australia—Using maps to understand spatial patterns in disease epidemics is nothing new. Nineteenth century epidemiologist John Snow’s cholera map was a game-changer, allowing him to trace cholera’s devastating path at the most granular, household level. Within the HIV field, multi-colored push pins and paper maps were being used just a few years ago to identify the location of existing health facilities in order to inform where facilities were still needed in order to increase coverage and inform strategic planning.

But gone are the days when maps existed in folded accordion rectangles, purchased from a book store or buried within the pages of an atlas. Today, anyone with a smart device—a phone, a tablet, a computer—can view a street-level map of virtually any location on earth. 

Blog AIDS 2014, 20 July 2014

20th International AIDS ConferenceAfter two years of planning and preparation, the International AIDS Conference is around the corner. The International Community of Women living with HIV [ICW] has several dynamic women presenting at; plenary sessions, symposia, workshops and the cultural program. The Women's Networking Zone [WNZ], a space open to the public, will have an exciting program of presentations by speakers, from every corner of the globe, addressing access to treatments and services, sexual and reproductive rights, discrimination and violence, and criminalization and justice.

Young women living with HIV will address both the opening and closing plenaries, with Ayu Oktariani from Indonesia, backed by thirty people from the Asia-Pacific region in traditional dress, welcoming delegates on behalf of the community, and Violent Banda from Malawi, a young woman born with HIV, taking the banner for the community onto the next conference in Durban in 2016.

JPNN, 20 Juli 2014

SURABAYA – Pasca penutupan lokalisasi Dolly-Jarak, Pemkot Surabaya dihadapkan pada pekerjaan besar untuk memantau penderita HIV/AIDS. Semua instansi dikerahkan untuk tetap mengendalikan penularan penyakit berbahaya itu dari berbagai sisi.

Langkah utama pemkot adalah menggerakkan 62 puskesmas yang tersebar di seluruh Surabaya. Tenaga medis di puskesmas itu telah dibekali kemampuan dan peralatan untuk mendeteksi penyakit HIV/AIDS. Mereka akan secara aktif mencari orang-orang yang diduga menderita penyakit tersebut. "Petugas bisa mendatangi orang yang dicurigai dan mengetesnya," kata Kepala Pengendalian Masalah Kesehatan Dinas Kesehatan Surabaya dr Mira Novia, Sabtu (19/7).

Medical Xpress, 19 July 2014

Among heterosexual African couples in which the male was HIV positive and the female was not, receipt of antiretroviral pre-exposure preventive (PrEP) therapy did not result in significant differences in pregnancy incidence, birth outcomes, and infant growth compared to females who received placebo, according to a study in the July 23/30 issue of JAMA, a theme issue on HIV/AIDS. The authors note that these findings do not provide a definitive conclusion regarding the safety of PrEP therapy prior to pregnancy. The issue is being released early to coincide with the International AIDS Conference.

Antiretroviral pre-exposure prophylaxis as daily oral tenofovir disoproxil fumarate (TDF) and co-formulated emtricitabine/tenofovir disoproxil fumarate (FTC+TDF) has been demonstrated to be efficacious for the prevention of human immunodeficiency virus (HIV) acquisition in diverse populations. PrEP could be an important component of safer conception strategies for women at risk for HIV infection, including those in HIV-serodiscordant couples (i.e., in which only one member is HIV infected), but the effect on pregnancy outcomes is not well defined, according to background information in the article.

Penelitian

Knowledge Hub

knowledgehub

knowledgehub

knowledgehub

Informasi

sejarahaids sistemkesehatan kebijakankesehatan kebijakanaids

Didukung oleh

AusAID